Krzysztof Karolak is an experienced professional in the clinical research field, currently serving as TMF Study Owner and TMF Lead at Pfizer since October 2020. Prior experience includes roles as Clinical Trial Associate at Gaea OÜ, TMF Specialist II at ICON plc, Clinical Project Administrator at EastHORN Clinical Services, and Study Coordinator at Synexus Clinical Research Ltd. Krzysztof holds a Bachelor's degree in Physiotherapy and a Master's degree in Physiotherapy from Akademia Medyczna Nauk Stosowanych i Holistycznych and Uniwersytet Jana Kochanowskiego, respectively, alongside a Postgraduate degree in the Methodology of Clinical Trials from the Medical University of Warsaw. Additionally, Krzysztof completed a Software Tester program at the Software Development Academy.